Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 346

1.

Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.

Adam Y, McIntyre JA, De Bruyn G.

S Afr Med J. 2012 Nov 22;103(1):34-9. doi: 10.7196/samj.6124.

PMID:
23237122
2.

Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.

Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.

J Med Screen. 2008;15(2):97-104. doi: 10.1258/jms.2008.007061.

PMID:
18573778
3.

Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study.

Gontijo RC, Derchain SF, Roteli-Martins C, Bragança JF, Sarian LO, Morais SS, Maeda MY, Longatto-Filho A, Syrjänen KJ.

Eur J Obstet Gynecol Reprod Biol. 2007 Aug;133(2):239-46. Epub 2006 Jun 30.

PMID:
16814450
4.

High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.

Sultana F, English DR, Simpson JA, Canfell K, Gertig DM, Saville M.

Int J Cancer. 2014 Sep 1;135(5):1213-9. doi: 10.1002/ijc.28756. Epub 2014 Mar 13.

5.

Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear.

Berkhof J, Bulkmans NW, Bleeker MC, Bulk S, Snijders PJ, Voorhorst FJ, Meijer CJ.

Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1268-73.

6.

HPV testing in primary screening of older women.

Cuzick J, Beverley E, Ho L, Terry G, Sapper H, Mielzynska I, Lorincz A, Chan WK, Krausz T, Soutter P.

Br J Cancer. 1999 Oct;81(3):554-8.

7.

Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.

Bansal M, Zhao C.

J Low Genit Tract Dis. 2011 Apr;15(2):105-9. doi: 10.1097/LGT.0b013e3181f41ee4.

PMID:
21317806
8.

Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.

Strander B, Andersson-Ellström A, Milsom I, Rådberg T, Ryd W.

Cancer. 2007 Oct 25;111(5):285-91.

9.
10.

Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.

Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.

Eur J Gynaecol Oncol. 2004;25(5):577-84.

PMID:
15493169
11.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

PMID:
12509400
12.

Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.

Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, Miotti P, Anastos K, Moxley M, Muderspach LI, Melnick S.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):432-42.

PMID:
11511819
13.

Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study.

Chalermchockcharoenkit A, Chayachinda C, Thamkhantho M, Komoltri C.

BMC Infect Dis. 2011 Jan 7;11:8. doi: 10.1186/1471-2334-11-8.

14.

Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.

Luyten A, Scherbring S, Reinecke-Lüthge A, Braun BE, Pietralla M, Theiler K, Petry KU.

J Clin Virol. 2009 Nov;46 Suppl 3:S5-10. doi: 10.1016/S1386-6532(09)70294-X.

PMID:
20129072
15.
16.

Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.

Firnhaber C, Goeieman B, Faesen M, Levin S, Williams S, Rameotshela S, Swarts A, Michelow P, Omar T, Williamson AL, Allan B, Schnippel K, Smith JS.

PLoS One. 2016 Jan 5;11(1):e0144905. doi: 10.1371/journal.pone.0144905. eCollection 2016.

18.

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance, after six months delay: a three-year experience in an Iranian university hospital.

Yarandi F, Shojaei H, Eftekhar Z, Izadi-Mood N.

Aust N Z J Obstet Gynaecol. 2009 Apr;49(2):207-10. doi: 10.1111/j.1479-828X.2009.00960.x.

PMID:
19432613
19.

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.

Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J.

J Natl Cancer Inst. 2004 Feb 18;96(4):280-93.

PMID:
14970277
20.

Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.

Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC.

Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):104-9.

PMID:
15950365

Supplemental Content

Support Center